Electrophysiological assessment of the effect of intrathecal baclofen in spastic children

[1]  B. Ashworth.  PRELIMINARY TRIAL OF CARISOPRODOL IN MULTIPLE SCLEROSIS. , 1964, The Practitioner.

[2]  B. Shahani,et al.  Human Flexor Spasms , 1973 .

[3]  J. Desmedt,et al.  New Developments in Electromyography and Clinical Neurophysiology , 1973 .

[4]  M. Hugon,et al.  Exteroceptive Reflexes to Stimulation of the Sural Nerve in Normal Man , 1973 .

[5]  Landau Wm.  Editorial: Spasticity: the fable of a neurological demon and the emperor's new therapy. , 1974 .

[6]  D. Middlemiss,et al.  (–)Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor , 1980, Nature.

[7]  E. Pedersen,et al.  The effect of the GABA‐agonist, progabide, on stretch and flexor reflexes and on voluntary power in spastic patients , 1984, Acta neurologica Scandinavica.

[8]  P. Delwaide.  Electrophysiological analysis of the mode of action of muscle relaxants in spasticity , 1985, Annals of neurology.

[9]  N. Bowery,et al.  GABAA and GABAB receptor site distribution in the rat central nervous system , 1987, Neuroscience.

[10]  R. Penn,et al.  Local-spinal Therapy of Spasticity , 1988, Springer Berlin Heidelberg.

[11]  D. Dralle,et al.  Pharmacokinetics of Intrathecal Baclofen , 1988 .

[12]  M. Latash,et al.  Effects of intrathecal baclofen on voluntary motor control in spastic paresis. , 1990, Journal of neurosurgery.

[13]  J. Jankovic,et al.  Intrathecal baclofen for intractable axial dystonia , 1991, Neurology.

[14]  Milanov Ig.  Flexor reflex for assessment of common interneurone activity in spasticity. , 1992 .

[15]  W Z Rymer,et al.  Objective quantification of spastic hypertonia: correlation with clinical findings. , 1992, Archives of physical medicine and rehabilitation.

[16]  E. Stewart-Wynne,et al.  Increased dystonia after intrathecal baclofen , 1992, Neurology.

[17]  P. Rossini,et al.  Non-invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application. Report of an IFCN committee. , 1994, Electroencephalography and clinical neurophysiology.

[18]  R. Casale,et al.  Reduction of spastic hypertonia in patients with spinal cord injury: a double-blind comparison of intravenous orphenadrine citrate and placebo. , 1995, Archives of physical medicine and rehabilitation.

[19]  B. Steinhoff,et al.  Effects of antiepileptic drugs on motor cortex excitability in humans: A transcranial magnetic stimulation study , 1996, Annals of neurology.

[20]  A. L. Albright.  Intrathecal Baclofen in Cerebral Palsy Movement Disorders , 1996, Journal of child neurology.

[21]  A. L. Albright.  Topical Review: Baclofen in the Treatment of Cerebral Palsy , 1996 .

[22]  M. Brin,et al.  Use of intrathecal baclofen in the treatment of patients with dystonia. , 1996, Archives of neurology.

[23]  B. Bussel,et al.  Intrathecal baclofen administration for control of severe spinal spasticity: functional improvement and long-term follow-up. , 1996, Archives of physical medicine and rehabilitation.

[24]  Miyabi Tanaka,et al.  Magnetic stimulation of motor cortex in children: maturity of corticospinal pathway and problem of clinical application , 1997, Brain and Development.

[25]  F Mauguière,et al.  Clinical use of polysynaptic flexion reflexes in the management of spasticity with intrathecal baclofen. , 1997, Electroencephalography and clinical neurophysiology.

[26]  B Conrad,et al.  Continuous intrathecal baclofen infusions induced a marked increase of the transcranially evoked silent period in a patient with generalized dystonia , 1998, Muscle & nerve.

[27]  M. Painter,et al.  Infusion of intrathecal baclofen for generalized dystonia in cerebral palsy. , 1998, Journal of neurosurgery.

[28]  W. Paulus,et al.  Motor system excitability in healthy children: developmental aspects from transcranial magnetic stimulation. , 1999, Electroencephalography and clinical neurophysiology. Supplement.

[29]  J. VanSwearingen,et al.  Reliability and responsiveness of the Barry-Albright Dystonia Scale. , 1999 .

[30]  M. Dimitrijevic,et al.  Intrathecal Baclofen Therapy for Spinal Origin Spasticity: Spinal Cord Injury, Spinal Cord Disease, and Multiple Sclerosis , 1999, Neuromodulation : journal of the International Neuromodulation Society.

[31]  Guy Cheron,et al.  Effect of intrathecal baclofen on gait control in human hereditary spastic paraparesis , 2000, Neuroscience Letters.

[32]  G. Cheron,et al.  Intrathecal baclofen normalizes motor strategy for squatting in familial spastic paraplegia: a case study , 2000, Neurophysiologie Clinique/Clinical Neurophysiology.

[33]  M. Fitzgerald,et al.  Flexion reflex responses in biceps femoris and tibialis anterior in human neonates. , 2000, Early human development.

[34]  J. Nielsen,et al.  The effect of baclofen on the transmission in spinal pathways in spastic multiple sclerosis patients , 2000, Clinical Neurophysiology.

[35]  M. Brin,et al.  Intrathecal baclofen for dystonia: Benefits and complications during six years of experience , 2000, Movement disorders : official journal of the Movement Disorder Society.

[36]  Fabrizio Pisano,et al.  Quantitative measures of spasticity in post-stroke patients , 2000, Clinical Neurophysiology.

[37]  G. Cheron,et al.  ‘Linking motor impairment to function’ , 2000, Developmental medicine and child neurology.

[38]  F. Glocker,et al.  Inhibitory conditioning stimulus in transcranial magnetic stimulation reduces the number of excited spinal motor neurons , 2001, Clinical Neurophysiology.

[39]  A. L. Albright,et al.  Intrathecal baclofen for generalized dystonia. , 2001, Developmental medicine and child neurology.

[40]  J. J. van Hilten,et al.  Intrathecal baclofen treatment of dystonia in reflex sympathetic dystrophy , 2002 .

[41]  J. Jankovic,et al.  Soleus H-reflex measures in patients with focal and generalized dystonia , 2003, Clinical Neurophysiology.

[42]  Charles Capaday,et al.  The effects of baclofen on the stretch reflex parameters of the cat , 2004, Experimental Brain Research.